• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Annals of Internal Medicine embargoed news; Catheter ablation superior to standard drug

Bioengineer by Bioengineer
December 24, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

1. Catheter ablation superior to standard drug therapy for heart failure

Abstract: http://annals.org/aim/article/doi/10.7326/M18-0992

URLs go live when the embargo lifts

A meta-analysis of randomized controlled trials found that catheter ablation was superior to conventional drug therapy alone for patients with atrial fibrillation and heart failure. Findings are published in Annals of Internal Medicine.

Atrial fibrillation is associated with thromboembolic stroke, systemic embolism, and decompensated heart failure. Catheter ablation is an established therapeutic strategy for atrial fibrillation, but guidelines recommend caution in certain patients. The benefits and harms of catheter ablation versus drug therapy for patients with atrial fibrillation have not been firmly established.

Researchers from Icahn School of Medicine at Mount Sinai reviewed six published randomized controlled trials to compare the benefits and harms between catheter ablation and standard drug therapy (rate or rhythm control medications) in adult patients with atrial fibrillation and heart failure. Their analysis showed that compared to medication, catheter ablation was associated with reductions in all-cause mortality and heart failure hospitalizations and improvements in left ventricular ejection fraction; quality of life; cardiopulmonary exercise capacity; and 6-minute walk test distance, with no statistically significant increase in serious adverse events.

The major adverse events rates observed in the pooled analysis were 7.2 percent in the ablation group and 3.8 percent in the standard therapy group. Despite the complications associated with catheter ablation, the authors explain that the long-term benefits in all-cause mortality, heart failure hospitalizations, and overall clinical outcomes must be weighed in clinical decision making.

Media contact: For an embargoed PDF, please contact Lauren Evans at [email protected]. To interview the lead author, Vivek Reddy, MD, please contact Wendi Chason at [email protected].

2. Proposed technique prevents confused patients from dislodging central line

Abstract: http://annals.org/aim/article/doi/10.7326/L18-0439

URLs go live when the embargo lifts

A proposed technique for placing a central venous catheter that may prevent confused patients from pulling it out or dislodging it easily. Findings from a case report are published in Annals of Internal Medicine.

Sometimes patients, particularly confused patients, dislodge or pull out central venous catheters inadvertently or intentionally. Although this occurrence is uncommon, it is not rare, and it may have negative consequences.

Physicians from Beth Israel Deaconess Medical Center and Harvard Medical School saw a 77-year-old patient with waxing and waning mental status who required dialysis for chronic kidney failure. The patient became confused and repeatedly pulled out his hemodialysis catheters. Since he was unsuitable for an arteriovenous access and the medical literature offered no solution, the physicians developed a novel technique. They placed a right external jugular vein catheter, tunneling subcutaneously to exit from the patient’s upper back, near the midline, just below his neck. It was out of reach to the patient, but not in an area where it would cause pressure on his skin when he was lying on his back. It worked well enough that the authors suggest clinicians consider this placement when caring for patients at risk for central line dislodgement.

Media contact: For an embargoed PDF, please contact Lauren Evans at [email protected]. To interview the lead author, Robert S. Brown, MD, please contact Jacqueline Mitchell at [email protected].

###

Also in this issue:

Testing Novel payment and Delivery Approaches Through the Veterans Health Administration’s New Center for Innovation

Steven D. Pizer, PhD; Austin B. Frakt, PhD; Kyle Sheetz, MD, MS; Carolyn Clancy, MD

Ideas and Opinions

Abstract: http://annals.org/aim/article/doi/10.7326/M18-2225

Media Contact
Lauren Evans
[email protected]
215-351-2513

Tags: CardiologyHealth Care Systems/ServicesHealth ProfessionalsInternal MedicineMedicine/HealthPublic HealthSurgery
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

New Research Explores the Brain as a Potential Target for Type 1 Diabetes Treatments

August 2, 2025
Macrophage-T Cell Interaction Boosts SLAMF1 in TB Defense

Macrophage-T Cell Interaction Boosts SLAMF1 in TB Defense

August 2, 2025

Strawberry Notch 1 Protects Neurons by Regulating Yeats4

August 2, 2025

What “And” vs. “Then” Reveal About Hospital Visits: Insights from Online Reviews

August 1, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10
  • Sustainability Accelerator Chooses 41 Promising Projects Poised for Rapid Scale-Up

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Research Explores the Brain as a Potential Target for Type 1 Diabetes Treatments

Macrophage-T Cell Interaction Boosts SLAMF1 in TB Defense

Strawberry Notch 1 Protects Neurons by Regulating Yeats4

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.